{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:05Z","timestamp":1789842845941,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aace.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T02:57:15Z","timestamp":1730861835000},"page":"66-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-8418","authenticated-orcid":false,"given":"Kevin S.","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra N.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie M.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aace.2024.11.002_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejim.2007.03.003","article-title":"Thyrotoxic hypokalemic periodic paralysis: an overlooked pathology in western countries","volume":"18","author":"Pompeo","year":"2007","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.aace.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.1989.00390110139031","article-title":"Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings","volume":"149","author":"Kelley","year":"1989","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.aace.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1210\/jcem-17-12-1454","article-title":"The association of periodic paralysis and hyperthyroidism in Japan","volume":"17","author":"Okinaka","year":"1957","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5538","key":"10.1016\/j.aace.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bmj.1.5538.451","article-title":"Periodic paralysis complicating thyrotoxicosis in Chinese","volume":"1","author":"McFadzean","year":"1967","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.aace.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/thy.2008.0364","article-title":"Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily","volume":"19","author":"Takata","year":"2009","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.aace.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management","volume":"17","author":"Vicente","year":"2017","journal-title":"Drugs R"},{"issue":"3","key":"10.1016\/j.aace.2024.11.002_bib7","first-page":"257","article-title":"Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting","volume":"33","author":"Benichou","year":"1991","journal-title":"Nouv Rev Fr Hematol"},{"issue":"6","key":"10.1016\/j.aace.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1468-1331.2008.02132.x","article-title":"Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks","volume":"15","author":"Hsieh","year":"2008","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.aace.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-13-0381","article-title":"A\u00a010-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants","volume":"169","author":"Chang","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.aace.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1530\/EJE-09-0553","article-title":"Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years","volume":"161","author":"Shiang","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.aace.2024.11.002_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.159.6.601","article-title":"Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes","volume":"159","author":"Manoukian","year":"1999","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.aace.2024.11.002_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajem.2004.09.016","article-title":"Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis","volume":"22","author":"Lu","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.aace.2024.11.002_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/694023","article-title":"Lithium carbonate in the treatment of Graves' disease with ATD-induced hepatic injury or leukopenia","volume":"2015","author":"Zheng","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"7960","key":"10.1016\/j.aace.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(76)90414-1","article-title":"Lithium carbonate in the treatment of thyrotoxicosis. A controlled trial","volume":"1","author":"Kristensen","year":"1976","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.aace.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.aace.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1196\/annals.1320.015","article-title":"Effects of carnitine on thyroid hormone action","volume":"1033","author":"Benvenga","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.aace.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1210\/jcem.86.8.7747","article-title":"Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial","volume":"86","author":"Benvenga","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.aace.2024.11.002_bib18","first-page":"29","article-title":"Current and emerging treatment options for Graves' hyperthyroidism","volume":"6","author":"Abraham","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.aace.2024.11.002_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7819-10-21","article-title":"Surgical treatment for thyrotoxic hypokalemic periodic paralysis: case report","volume":"10","author":"Lin","year":"2012","journal-title":"World J Surg Oncol"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:30:09Z","timestamp":1736814609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060524001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2376060524001184"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2024.11.002","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}